Role of CTL host responses and their implication for tumorigenicity testing and the use of tumour cells as vaccine substrate.

S. Tevethia, T. Beachy, T. Schell, J. Lippolis, R. Newmaster, L. Mylin, M. J. Tevethia

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Viral oncogenes, mutated cellular oncogenes, or other adventitious agents that might contaminate vaccine preparations on inoculation of the host will encounter a T cell-mediated immune response which will play a determining role in the progression of neoplastic events or replication of contaminating viral agents. Using SV40 T antigen tumour systems as a model we discuss the regions of the oncoprotein that have an impact on tumourigenicity and the role of CD8 T lymphocyte immune responses in eliminating potential tumour cells. In addition, we discuss measures that counteract T cell immune responses to abrogate T cell-mediated immunosurveillance.

Original languageEnglish (US)
Pages (from-to)109-121; discussion 143-160
JournalDevelopments in biologicals
Volume106
StatePublished - 2001

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Immunology
  • Pharmacology

Fingerprint

Dive into the research topics of 'Role of CTL host responses and their implication for tumorigenicity testing and the use of tumour cells as vaccine substrate.'. Together they form a unique fingerprint.

Cite this